Helicobacter Pylori Local Prevalence and Antibiotic Resistance

Recruiting Observational Study
Helicobacter Pylori Infection Helicobacter Pylori Gastritis Drug Resistant Bacterial Infection Antibiotic Resistant Infection Gastric Cancer Microbial Colonization
Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
20,000 (estimated)
Sponsor
Technical University of Munich · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The clinical management of H. pylori infection depends essentially on two factors, prevalence and local resistance. In Germany, only limited data from rather small cohorts currently exist regarding both factors. Knowledge of the current prevalence (accounting for socioeconomic factors and age) is important for the selection of suitable detection methods, as this influences the positive and negativ…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Minimum age of 18 years * informed consent for HelicoPTER study * informed consent for HEPY biobank Exclusion Criteria: * no capacity to consent
Contacts

Markus Gerhard, Prof.

+49894140

markus.gerhard@tum.de

CONTACT